Abstract |
Oral telmisartan/hydrochlorothiazide ( HCTZ) combines two antihypertensive agents, a selective angiotensin II receptor antagonist with a long half-life and once-daily administration, and a thiazide diuretic. In two large, 8-week, double-blind trials, patients with hypertension unresponsive to monotherapy who received combined telmisartan/ HCTZ 80/12.5 or 40/12.5 mg/day, achieved significantly larger reductions in diastolic and systolic blood pressure (BP), than recipients of continued telmisartan monotherapy (p < 0.05 for all). Compliance with telmisartan/ HCTZ 80/12.5 mg/day was 98.9%. In patients with hypertension, telmisartan/ HCTZ resulted in similar BP reductions to oral enalapril/ HCTZ and atenolol/ HCTZ in 26-week double-blind trials and greater reductions than oral losartan/ HCTZ 50/12.5 mg/day in a 6-week randomised open-label trial (p < 0.001). Up to one-third of patients with hypertension initially responsive to telmisartan 40 or 80 mg/day in a 4-year study required the eventual addition of HCTZ 12.5 or 25 mg/day and/or another agent to maintain BP control. BP was controlled in about 75% of these by adding only HCTZ. In clinical trials of up to 4 years, including elderly patients, telmisartan/ HCTZ had similar tolerability to placebo, with few reports of hypokalaemia. Most adverse events were mild to moderate.
|
Authors | Caroline Fenton, Gillian M Keating, Lesley J Scott |
Journal | Drugs
(Drugs)
Vol. 63
Issue 19
Pg. 2013-26; discussion 2027-8
( 2003)
ISSN: 0012-6667 [Print] New Zealand |
PMID | 12962518
(Publication Type: Journal Article, Review)
|
Chemical References |
- Angiotensin-Converting Enzyme Inhibitors
- Benzimidazoles
- Benzoates
- Diuretics
- Drug Combinations
- telmisartan, hydrochlorothiazide drug combination
- Hydrochlorothiazide
- Telmisartan
|
Topics |
- Angiotensin-Converting Enzyme Inhibitors
(pharmacokinetics, pharmacology, therapeutic use)
- Benzimidazoles
(pharmacokinetics, pharmacology, therapeutic use)
- Benzoates
(pharmacokinetics, pharmacology, therapeutic use)
- Clinical Trials as Topic
- Diuretics
(pharmacokinetics, pharmacology, therapeutic use)
- Drug Combinations
- Humans
- Hydrochlorothiazide
(pharmacokinetics, pharmacology, therapeutic use)
- Hypertension
(drug therapy)
- Telmisartan
|